Northwestern Medicine investigators have developed a new avenue to reprogram compromised immune cells to act against tumors, ...

Ongoing launch of CASGEVY ® continues to gain momentum; new cell patient collection initiations expected to significantly grow in 2025- -More than 50 authorized treatment centers (ATCs) activated ...

Ongoing launch of CASGEVY® continues to gain momentum; new cell patient collection initiations expected to significantly ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Scientists at UC San Francisco have pioneered a groundbreaking approach to fighting cancer using engineered fat cells. By ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

T-cell therapy represents a groundbreaking advancement in the field of immuno-oncology. This innovative treatment involves ...

And we’ve also made additional edits using the CRISPR system that makes them autologous ... except for one-off patients that may be immune -- that may not have an immune system that’s competent.

Immune checkpoint inhibitors boost the immune ... This would either cause the cancer cells to die off or prevent them from growing. CRISPR is an example of gene editing that lets researchers ...

A team of researchers in the United States has developed a groundbreaking cancer treatment that starves tumors by leveraging ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...